Resumen de acción EQS
Equasens Société anonyme ofrece soluciones informáticas sanitarias en Europa. Saber más
| Puntuación del snowflake | |
|---|---|
| Valoración | 5/6 |
| Crecimiento futuro | 2/6 |
| Rendimiento pasado | 2/6 |
| Salud financiera | 6/6 |
| Dividendos | 5/6 |
Recompensas
Análisis de riesgos
No se han detectado riesgos en EQS a partir de nuestros controles de riesgos.
Competidores de Equasens Société anonyme
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | €40.70 |
| Máximo en las últimas 52 semanas | €67.40 |
| Mínimo de 52 semanas | €40.55 |
| Beta | 0.89 |
| 1Cambio en 1 mes | -20.35% |
| Variación en 3 meses | -14.32% |
| Cambio de 1 año | -29.09% |
| 3Variación en 3 años | -52.51% |
| Variación en 5 años | -29.71% |
| Variación desde la OPV | 855.40% |
Noticias y actualizaciones recientes
The Equasens Société anonyme (EPA:EQS) First-Quarter Results Are Out And Analysts Have Published New Forecasts
Oct 03
Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?
Sep 28Equasens Société anonyme's (EPA:EQS) Intrinsic Value Is Potentially 75% Above Its Share Price
Jul 15Equasens Société anonyme's (EPA:EQS) Upcoming Dividend Will Be Larger Than Last Year's
Jun 22Recent updates
The Equasens Société anonyme (EPA:EQS) First-Quarter Results Are Out And Analysts Have Published New Forecasts
Oct 03Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?
Sep 28Equasens Société anonyme's (EPA:EQS) Intrinsic Value Is Potentially 75% Above Its Share Price
Jul 15Equasens Société anonyme's (EPA:EQS) Upcoming Dividend Will Be Larger Than Last Year's
Jun 22Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?
Jun 07Equasens Société anonyme (EPA:EQS) Is Aiming To Keep Up Its Impressive Returns
Apr 03At €51.10, Is It Time To Put Equasens Société anonyme (EPA:EQS) On Your Watch List?
Mar 08Some Confidence Is Lacking In Equasens Société anonyme's (EPA:EQS) P/E
Feb 14Estimating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)
Jan 27Should You Investigate Equasens Société anonyme (EPA:EQS) At €59.70?
Nov 29These 4 Measures Indicate That Equasens Société anonyme (EPA:EQS) Is Using Debt Safely
Oct 28A Look At The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)
Sep 27Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?
Aug 05Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.15
Jun 11Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year
May 22Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year
May 08What Does Equasens Société anonyme's (EPA:EQS) Share Price Indicate?
Apr 04Equasens Société anonyme (EPA:EQS) Will Want To Turn Around Its Return Trends
Feb 13Calculating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)
Jan 26At €71.60, Is Equasens Société anonyme (EPA:EQS) Worth Looking At Closely?
Dec 21Should You Be Adding Equasens Société anonyme (EPA:EQS) To Your Watchlist Today?
Dec 07Here's What's Concerning About Equasens Société anonyme's (EPA:EQS) Returns On Capital
Nov 12Is Equasens Société anonyme (EPA:EQS) Trading At A 26% Discount?
Oct 27Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?
Oct 12When Should You Buy Equasens Société anonyme (EPA:EQS)?
Sep 09With EPS Growth And More, Equasens Société anonyme (EPA:EQS) Makes An Interesting Case
Aug 24Equasens Société anonyme (EPA:EQS) Might Be Having Difficulty Using Its Capital Effectively
Jul 28Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.05
Jun 10Pharmagest Interactive (EPA:PHA) Has Announced That It Will Be Increasing Its Dividend To €1.05
May 27Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?
May 22Here's What Pharmagest Interactive's (EPA:PHA) Strong Returns On Capital Mean
Apr 25Are Investors Undervaluing Pharmagest Interactive SA (EPA:PHA) By 28%?
Feb 23Here's Why I Think Pharmagest Interactive (EPA:PHA) Might Deserve Your Attention Today
Feb 09Is Pharmagest Interactive SA (EPA:PHA) Potentially Undervalued?
Jan 25Many Would Be Envious Of Pharmagest Interactive's (EPA:PHA) Excellent Returns On Capital
Jan 06Pharmagest Interactive (EPA:PHA) Could Easily Take On More Debt
Nov 14Is There An Opportunity With Pharmagest Interactive SA's (EPA:PHA) 20% Undervaluation?
Oct 30Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?
Sep 28Is Pharmagest Interactive SA (EPA:PHA) Trading At A 20% Discount?
Jul 18Pharmagest Interactive (EPA:PHA) Will Want To Turn Around Its Return Trends
Jun 24Does Pharmagest Interactive (EPA:PHA) Deserve A Spot On Your Watchlist?
Apr 08Pharmagest Interactive SA (EPA:PHA) Is An Attractive Dividend Stock - Here's Why
Mar 24Pharmagest Interactive SA's (EPA:PHA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Mar 03Our Take On The Returns On Capital At Pharmagest Interactive (EPA:PHA)
Feb 09
Shareholders of Pharmagest Interactive (EPA:PHA) Must Be Delighted With Their 500% Total Return
Jan 12What To Know Before Buying Pharmagest Interactive SA (EPA:PHA) For Its Dividend
Dec 15Rentabilidad de los accionistas
| EQS | FR Healthcare Services | Mercado FR | |
|---|---|---|---|
| 7D | -7.1% | -2.7% | -0.3% |
| 1Y | -29.1% | -12.0% | -3.5% |
Rentabilidad vs. Industria: Los resultados de EQS fueron inferiores a los de la industria French Healthcare Services, que obtuvo un rendimiento del -12% el año pasado.
Rentabilidad vs. Mercado: EQS obtuvo unos resultados inferiores a los del mercado French, que fueron del -3.5% el año pasado.
Volatilidad de los precios
| EQS volatility | |
|---|---|
| EQS Average Weekly Movement | 5.0% |
| Healthcare Services Industry Average Movement | 5.9% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in FR Market | 9.2% |
| 10% least volatile stocks in FR Market | 2.2% |
Precio estable de las acciones: EQS no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de EQS (5%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1996 | 1,271 | Denis Supplisson | equasens.com |
Equasens Société anonyme proporciona soluciones informáticas sanitarias en Europa. Ofrece id. PATIENT, un software empresarial; id.
Resumen de fundamentos de Equasens Société anonyme
| Estadísticas fundamentales de EQS | |
|---|---|
| Capitalización bursátil | €611.77m |
| Beneficios(TTM) | €42.25m |
| Ingresos (TTM) | €215.16m |
14.5x
Ratio precio-beneficio (PE)2.8x
Ratio precio-ventas (PS)¿Está EQS sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de EQS | |
|---|---|
| Ingresos | €215.16m |
| Coste de los ingresos | €151.30m |
| Beneficio bruto | €63.86m |
| Otros gastos | €21.60m |
| Beneficios | €42.25m |
Últimos beneficios comunicados
Jun 30, 2024
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 2.81 |
| Margen bruto | 29.68% |
| Margen de beneficio neto | 19.64% |
| Ratio deuda/patrimonio | 24.0% |
¿Cómo se ha desempeñado EQS a largo plazo?
Ver rendimiento histórico y comparativa